Chief Financial Officer · RECURSION PHARMACEUTICALS, INC. · Class A Common Stock
Side
SELL
Value
$89K
Shares
21.4K
Price
$4.18
Executed
Dec 29, 2025
Disclosed
Dec 30, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 29 executedDec 30, 2025 disclosed
RXRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Taylor Ben R filed this Form 4 reporting a open-market sale of RXRX on Dec 29, 2025. It became public on Dec 30, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Taylor Ben Rcik:0001712276
Issuer
RECURSION PHARMACEUTICALS, INC.cik:0001601830
Revision history · 0
No field has changed since this record was first ingested.
